Developing Novel Personalized Cancer Vaccines
We are a Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies. Our mission is to improve the lives of patients by developing novel therapies to overcome the underlying mechanisms by which tumor cells escape immune recognition.
About Us